49
Participants
Start Date
October 22, 2018
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2026
AZD1775
AZD1775 blocks the activity of Wee1, a protein that helps to regulate how cells divide and grow. Certain cancer cells may be more vulnerable to having this process blocked
Dana Farber Cancer Institute, Boston
Collaborators (1)
AstraZeneca
INDUSTRY
Dana-Farber Cancer Institute
OTHER